Novo and rival Eli Lilly, which makes the GLP-1 weight-loss drug Zepbound, have reaped billions of dollars in profits since ...

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Meds like Wegovy are all over the news. But are they right for you, especially if you're older than the average user?By ...